Department for Oral, Cranio-Maxillofacial, and Facial Plastic Surgery, Frankfurt Orofacial Regenerative Medicine (FORM) Lab, University Hospital Frankfurt Goethe University, 60590, Frankfurt am Main, Germany.
Pain Therapy Center, Nice, France.
Clin Oral Investig. 2020 Oct;24(10):3485-3500. doi: 10.1007/s00784-020-03219-2. Epub 2020 Feb 17.
The present study evaluated the cellular tissue reaction of two equine-derived collagen hemostatic sponges (E-CHS), which differed in thickness after pressing, over 30 days in vivo. The inflammatory response during physiological wound healing in sham-operated animals was used as control group.
First, the E-CHS was pressed by applying constant pressure (6.47 ± 0.85 N) for 2 min using a sterile stainless-steel cylinder until the material was uniformly flattened. Consequently, the original (E-CHS), the pressed (P-E-CHS), as well as the control group (CG; sham operation) were studied independently. The 3 groups were evaluated in vivo after subcutaneous implantation in Wistar rats during 3, 15, and 30 days. Histochemical and immunohistochemical methods provided observations of biomaterial degradation rate, cellular inflammatory response, and vascularization pattern. A derivative of human blood known as platelet-rich fibrin (PRF) was used as an ex vivo model to simulate the initial biomaterial-cell interaction. Segments of E-CHS and P-E-CHS were cultivated for 3 and 6 days with PRF, and the release of pro-inflammatory proteins was measured using ELISA. PRF cultivated alone was used as a control group.
At day 3, the CG induced a statistically significant higher presence of monocytes/macrophages (CD68+), pro-inflammatory macrophages (M1; CCR7+), and pro-wound healing macrophages (M2; CD206+) compared to E-CHS and P-E-CHS. At the same time point, P-E-CHS induced a statistically significant higher presence of CD68+ cells compared to E-CHS. After 15 days, E-CHS was invaded by cells and vessels and showed a faster disintegration rate compared to P-E-CHS. On the contrary, cells and vessels were located only in the outer region of P-E-CHS and the biomaterial did not lose its structure and accordingly did not undergo disintegration. The experimental groups induced similar inflammatory reaction primarily with positive pro-inflammatory CD68+/CCR7+ macrophages and a low presence of multinucleated giant cells (MNGCs). At this time point, significantly lower CD68+/CCR7+ macrophages and no MNGCs were detected within the CG when compared to the experimental groups (P < 0.05). After 30 days, E-CHS and P-E-CHS were fully degraded. All groups showed similar inflammatory reaction shifted to a higher presence CD206+ macrophages. A low number of CCR7+ MNGCs were still observable in the implantation bed of both experimental groups. In the ex vivo model, the cells and fibrin from PRF penetrated E-CHS. However, in the case of P-E-CHS, the cells and fibrin stayed on the surface and did not penetrate towards materials central regions. The cultivation of P-E-CHS with PRF induced a statically significant higher release of pro-inflammatory proteins compared to the CG and E-CHS after 3 days.
Altering the original presentation of a hemostatic sponge biomaterial by pressing modified the initial biomaterial-cell interaction, delayed the early biomaterial's degradation rate, and altered the vascularization pattern. A pressed biomaterial seems to induce a higher inflammatory reaction at early time points. However, altering the biomaterial did not modify the polarization pattern of macrophages compared to physiologic wound healing. The ex vivo model using PRF was shown to be an effective model to simulate the initial biomaterial-cell interaction in vivo.
A pressed hemostatic sponge could be applied for guided tissue regeneration and guided bone regeneration. In that sense, within the limitations of this study, the results show that the same biomaterial may have two specific clinical indications.
本研究评估了两种不同厚度的马源性胶原止血海绵(E-CHS)的细胞组织反应,这两种止血海绵在体内 30 天后的压后厚度不同。使用假手术动物的生理伤口愈合中的炎症反应作为对照组。
首先,使用无菌不锈钢圆柱体对 E-CHS 施加 2 分钟的恒定压力(6.47±0.85N),将材料均匀压平,从而制备 E-CHS。然后,将原始的(E-CHS)、压后的(P-E-CHS)以及对照组(CG;假手术)分别进行研究。在 Wistar 大鼠皮下植入后,在第 3、15 和 30 天分别对这 3 组进行体内评估。组织化学和免疫组织化学方法提供了生物材料降解率、细胞炎症反应和血管形成模式的观察结果。一种称为富含血小板纤维蛋白(PRF)的人类血液衍生物被用作体外模型,以模拟初始生物材料-细胞相互作用。将 E-CHS 和 P-E-CHS 的片段与 PRF 培养 3 和 6 天,并使用 ELISA 测量促炎蛋白的释放。单独培养的 PRF 用作对照组。
在第 3 天,CG 诱导的单核细胞/巨噬细胞(CD68+)、促炎巨噬细胞(M1;CCR7+)和促伤口愈合巨噬细胞(M2;CD206+)的存在明显高于 E-CHS 和 P-E-CHS。同时,P-E-CHS 诱导的 CD68+细胞存在明显高于 E-CHS。在第 15 天,E-CHS 被细胞和血管侵袭,并显示出比 P-E-CHS 更快的崩解率。相反,细胞和血管仅位于 P-E-CHS 的外区,生物材料并未失去其结构,因此没有崩解。实验组主要诱导相似的炎症反应,表现为阳性的促炎 CD68+/CCR7+巨噬细胞和低多核巨细胞(MNGCs)的存在。此时,与实验组相比,CG 中明显检测到较少的 CD68+/CCR7+巨噬细胞和无 MNGCs(P<0.05)。在第 30 天时,E-CHS 和 P-E-CHS 已完全降解。所有组均显示出相似的炎症反应,向更高的 CD206+巨噬细胞倾斜。在两个实验组的植入床中仍可观察到少量的 CCR7+MNGCs。在体外模型中,PRF 的细胞和纤维渗透到 E-CHS 中。然而,在 P-E-CHS 的情况下,细胞和纤维停留在表面,没有向材料的中心区域渗透。与 CG 和 E-CHS 相比,P-E-CHS 与 PRF 培养 3 天后促炎蛋白的释放明显更高。
通过压制作生物材料的原始形态改变了初始的生物材料-细胞相互作用,延迟了早期生物材料的降解速度,并改变了血管形成模式。压制作的生物材料在早期可能会引起更高的炎症反应。然而,与生理伤口愈合相比,改变生物材料并没有改变巨噬细胞的极化模式。使用 PRF 的体外模型被证明是一种有效的模拟体内初始生物材料-细胞相互作用的模型。
压制作的止血海绵可用于引导组织再生和引导骨再生。在这项研究的限制范围内,结果表明,相同的生物材料可能具有两种特定的临床适应症。